100 related articles for article (PubMed ID: 29310262)
1. Nano-biotinylated liposome-based immunoassay for the ultrasensitive detection of protein biomarker in urine.
Liu P; Fang X; Cao H; Gu M; Kong J; Deng A
Talanta; 2018 Mar; 179():472-477. PubMed ID: 29310262
[TBL] [Abstract][Full Text] [Related]
2. A combination of urinary biomarker panel and PancRISK score for earlier detection of pancreatic cancer: A case-control study.
Debernardi S; O'Brien H; Algahmdi AS; Malats N; Stewart GD; Plješa-Ercegovac M; Costello E; Greenhalf W; Saad A; Roberts R; Ney A; Pereira SP; Kocher HM; Duffy S; Blyuss O; Crnogorac-Jurcevic T
PLoS Med; 2020 Dec; 17(12):e1003489. PubMed ID: 33301466
[TBL] [Abstract][Full Text] [Related]
3. Development of PancRISK, a urine biomarker-based risk score for stratified screening of pancreatic cancer patients.
Blyuss O; Zaikin A; Cherepanova V; Munblit D; Kiseleva EM; Prytomanova OM; Duffy SW; Crnogorac-Jurcevic T
Br J Cancer; 2020 Mar; 122(5):692-696. PubMed ID: 31857725
[TBL] [Abstract][Full Text] [Related]
4. Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma.
Radon TP; Massat NJ; Jones R; Alrawashdeh W; Dumartin L; Ennis D; Duffy SW; Kocher HM; Pereira SP; Guarner posthumous L; Murta-Nascimento C; Real FX; Malats N; Neoptolemos J; Costello E; Greenhalf W; Lemoine NR; Crnogorac-Jurcevic T
Clin Cancer Res; 2015 Aug; 21(15):3512-21. PubMed ID: 26240291
[TBL] [Abstract][Full Text] [Related]
5. Magnetic-Immuno-Loop-Mediated Isothermal Amplification Based on DNA Encapsulating Liposome for the Ultrasensitive Detection of P-glycoprotein.
Cao H; Fang X; Liu P; Li H; Chen W; Liu B; Kong J
Sci Rep; 2017 Aug; 7(1):9312. PubMed ID: 28839228
[TBL] [Abstract][Full Text] [Related]
6. Urine metallomics signature as an indicator of pancreatic cancer.
Schilling K; Larner F; Saad A; Roberts R; Kocher HM; Blyuss O; Halliday AN; Crnogorac-Jurcevic T
Metallomics; 2020 May; 12(5):752-757. PubMed ID: 32211672
[TBL] [Abstract][Full Text] [Related]
7. DNA encapsulating liposome based rolling circle amplification immunoassay as a versatile platform for ultrasensitive detection of protein.
Ou LJ; Liu SJ; Chu X; Shen GL; Yu RQ
Anal Chem; 2009 Dec; 81(23):9664-73. PubMed ID: 19877619
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive Diagnosis of Pancreatic Cancer Through Detection of Volatile Organic Compounds in Urine.
Arasaradnam RP; Wicaksono A; O'Brien H; Kocher HM; Covington JA; Crnogorac-Jurcevic T
Gastroenterology; 2018 Feb; 154(3):485-487.e1. PubMed ID: 29129714
[No Abstract] [Full Text] [Related]
9. Ultrasensitive detection of mucin 1 biomarker by immuno-loop-mediated isothermal amplification.
Cao H; Fang X; Li H; Li H; Kong J
Talanta; 2017 Mar; 164():588-592. PubMed ID: 28107977
[TBL] [Abstract][Full Text] [Related]
10. Sandwich immunoassay coupled with isothermal exponential amplification reaction: An ultrasensitive approach for determination of tumor marker MUC1.
Liu H; Zhang L; Xu Y; Chen J; Wang Y; Huang Q; Chen X; Liu Y; Dai Z; Zou X; Li Z
Talanta; 2019 Nov; 204():248-254. PubMed ID: 31357289
[TBL] [Abstract][Full Text] [Related]
11. Urinary TIMP-1 and MMP-2 levels detect the presence of pancreatic malignancies.
Roy R; Zurakowski D; Wischhusen J; Frauenhoffer C; Hooshmand S; Kulke M; Moses MA
Br J Cancer; 2014 Oct; 111(9):1772-9. PubMed ID: 25137018
[TBL] [Abstract][Full Text] [Related]
12. Immuno-PCR: An ultrasensitive immunoassay for biomolecular detection.
Chang L; Li J; Wang L
Anal Chim Acta; 2016 Mar; 910():12-24. PubMed ID: 26873464
[TBL] [Abstract][Full Text] [Related]
13. From Interface to Solution: Integrating Immunoassay with Netlike Rolling Circle Amplification for Ultrasensitive Detection of Tumor Biomarker.
Feng C; Bo B; Mao X; Shi H; Zhu X; Li G
Theranostics; 2017; 7(1):31-39. PubMed ID: 28042314
[TBL] [Abstract][Full Text] [Related]
14. Urine test can detect early stage pancreatic cancer.
Bagcchi S
Lancet Oncol; 2015 Sep; 16(9):e431. PubMed ID: 26256762
[No Abstract] [Full Text] [Related]
15. Discovery and Validation of Biomarkers That Distinguish Mucinous and Nonmucinous Pancreatic Cysts.
Park J; Yun HS; Lee KH; Lee KT; Lee JK; Lee SY
Cancer Res; 2015 Aug; 75(16):3227-35. PubMed ID: 26122842
[TBL] [Abstract][Full Text] [Related]
16. High-sensitive immunosensing of protein biomarker based on interfacial recognition-induced homogeneous exponential transcription.
Teng J; Huang L; Zhang L; Li J; Bai H; Li Y; Ding S; Zhang Y; Cheng W
Anal Chim Acta; 2019 Aug; 1067():107-114. PubMed ID: 31047141
[TBL] [Abstract][Full Text] [Related]
17. Identification and Validation of Novel Subtype-Specific Protein Biomarkers in Pancreatic Ductal Adenocarcinoma.
Kuhlmann L; Nadler WM; Kerner A; Hanke SA; Noll EM; Eisen C; Espinet E; Vogel V; Trumpp A; Sprick MR; Roesli CP
Pancreas; 2017 Mar; 46(3):311-322. PubMed ID: 27846146
[TBL] [Abstract][Full Text] [Related]
18. Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.
Mayerle J; Kalthoff H; Reszka R; Kamlage B; Peter E; Schniewind B; González Maldonado S; Pilarsky C; Heidecke CD; Schatz P; Distler M; Scheiber JA; Mahajan UM; Weiss FU; Grützmann R; Lerch MM
Gut; 2018 Jan; 67(1):128-137. PubMed ID: 28108468
[TBL] [Abstract][Full Text] [Related]
19. Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma.
Munding JB; Adai AT; Maghnouj A; Urbanik A; Zöllner H; Liffers ST; Chromik AM; Uhl W; Szafranska-Schwarzbach AE; Tannapfel A; Hahn SA
Int J Cancer; 2012 Jul; 131(2):E86-95. PubMed ID: 21953293
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic ductal adenocarcinoma is associated with a distinct urinary metabolomic signature.
Davis VW; Schiller DE; Eurich D; Bathe OF; Sawyer MB
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S415-23. PubMed ID: 23096698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
